Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System
OrthoSpineNews
JUNE 3, 2025
Notably, no device-related adverse events were reported in any patient at the one-year follow-up, underscoring the strong safety profile and promising clinical potential of VCFix. Patients, both with and without cement, experienced immediate and sustained reductions in pain levels, as assessed by the Numeric Pain Rating Scale (NPRS).
52 
Let's personalize your content